IFM-514 inhibited NLRP3 inflammasome and the subsequent caspase-1 proteolytic activation, thus preventing the development of NASH in ApoE-/- mice. The gene discussed is CASP1; the disease is metabolic dysfunction-associated steatohepatitis.